Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 16, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 19, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001140361-26-037158
Filed / recorded
Sep 19, 2026, 5:00 AM UTC
Added to OQRO
Oct 6, 2026, 8:46 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Roivant Sciences Ltd.
Issuer CIK
1635088
Ticker
ROIV
Reporting person
Keith S Manchester
Relationship
Director
Security
Common Shares
Table
Non-derivative (Table I)
Transaction date
Sep 16, 2026
Transaction code
A
Shares / units
5,054
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,753,457
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 16, 2027, subject generally to the reporting person's service as a director through such date.